Company intelligence / Profile preview

BioNordika

Ownership: Private
Development stage: Commercial

Overview

BioNordika is an active Nordic group specializing in distributing high-quality life science research products and services. It focuses on cell-, micro-, and molecular biology, immunology, diagnostics, sequencing solutions, custom oligonucleotides, biochemicals, instruments/consumables for academic and industrial customers across the Nordics. The company does not develop proprietary therapeutics or diagnostics but represents leading global suppliers.

Modalities: AntibodyBiochemicalCell culture mediaMolecular diagnostics reagents
Industry: Drug Discovery Services

Partnerships

Singleron BiotechnologiesAxol BioscienceEurocloneEurogentec

Beyond the preview

Go deeper on BioNordika.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioNordika.

Explore the full profile